FDA Orange Book · active-ingredient family
Estradiol; levonorgestrel
Estradiol; levonorgestrel is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:CLIMARA PRO · NDA 021258
1
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · film, extended release
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CLIMARA PRORLD | BAYER HLTHCARE | NDA 021258 | — | Nov 21, 2003 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Estradiol; levonorgestrel — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

